The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer
Open accessPublished version of a preprint
Abstract
Recent studies have identified a unique cancer-associated fibroblast (CAF) population termed antigen-presenting CAFs (apCAFs), characterized by the expression of major histocompatibility complex class II molecules, suggesting a function in regulating tumor immunity. Here, by integrating multiple single-cell RNA-sequencing studies and performing robust lineage-tracing assays, we find that apCAFs are derived from mesothelial cells. During pancreatic cancer progression, mesothelial cells form apCAFs by downregulating mesothelial features and gaining fibroblastic features, a process induced by interleukin-1 and transforming growth factor β. apCAFs directly ligate and induce naive CD4 + T cells into regulatory T cells (Tregs) in an antigen-specific manner. Moreover, treatment with an antibody targeting the mesothelial cell marker mesothelin can effectively inhibit mesothelial cell to apCAF transition and Treg formation induced by apCAFs. Taken together, our study elucidates how mesothelial cells may contribute to immune evasion in pancreatic cancer and provides insight on strategies to enhance cancer immune therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“lineage tracing analysis of perivascular fibroblasts, expressing the transcription factor Gli1, showed this population expands to form nearly half of pre-CAFs in PanINs and CAFs in cancer”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [144]
In the citing paper
“parenchymal fibroblasts, expressing Hoxb6 do not expand during carcinogenesis144”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [144]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrated analysis of multimodal single-cell data
Hao, Y., Hao, S., Andersen-Nissen, E., Mauck, W. M., Zheng, S., Butler, A., Lee, M. J., Wilk, A. J., Darby, C., Zagar, M., et al. (2020) · doi:10.1101/2020.10.12.335331 · Cited by 15,508
Comprehensive Integration of Single-Cell Data
Stuart, T., Butler, A., Hoffman, P., Hafemeister, C., Papalexi, E., Mauck, W. M., Hao, Y., Stoeckius, M., Smibert, P., & Satija, R. (2019) · Cell · doi:10.1016/j.cell.2019.05.031 · Cited by 15,453
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Zhou, Y., Zhou, B., Pache, L., Chang, M., Khodabakhshi, A. H., Tanaseichuk, O., Benner, C., & Chanda, S. K. (2019) · Nature Communications · doi:10.1038/s41467-019-09234-6 · Cited by 14,611
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Reversed graph embedding resolves complex single-cell trajectories
Qiu, X., Mao, Q., Tang, Y., Wang, L., Chawla, R., Pliner, H. A., & Trapnell, C. (2017) · Nature Methods · doi:10.1038/nmeth.4402 · Cited by 5,070
The biology and function of fibroblasts in cancer
Kalluri, R. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.73 · Cited by 4,366
Özdemir, B. C., Pentcheva-Hoang, T., Carstens, J. L., Zheng, X., Wu, C.-C., Simpson, T. R., Laklai, H., Sugimoto, H., Kahlert, C., Novitskiy, S. V., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.005 · Cited by 2,681
Hingorani, S. R., Wang, L., Multani, A. S., Combs, C., Deramaudt, T. B., Hruban, R. H., Rustgi, A. K., Chang, S., & Tuveson, D. A. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.023 · Cited by 2,609
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Öhlund, D., Handly-Santana, A., Biffi, G., Elyada, E., Almeida, A. S., Ponz-Sarvise, M., Corbo, V., Oni, T. E., Hearn, S. A., Lee, E. J., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20162024 · Cited by 2,590
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 540
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102296 · Cited by 50
Identification of cancer-associated fibroblasts subtypes in prostate cancer
Pan, J., Ma, Z., Лю, Б., Qian, H., Shao, X., Liu, J., Wang, Q., & Xue, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1133160 · Cited by 45
Tumor-associated fibrosis impairs the response to immunotherapy
Naik, A., & Leask, A. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.04.002 · Cited by 47
Guo, J., Wang, S., & Gao, Q. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1258538 · Cited by 47
Xu, Y., Li, W., Lin, S., Liu, B., Wu, P., & Li, L. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01204-2 · Cited by 50
Metastasis-associated fibroblasts in peritoneal surface malignancies
Ramos, C., Gerakopoulos, V., & Oehler, R. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02717-4 · Cited by 42
Cancer-on-a-chip for precision cancer medicine
Liu, L., Wang, H., Chen, R., Song, Y., Wei, W., Baek, D. S. H., Gillin, M., Kurabayashi, K., & Chen, W. (2025) · Lab on a Chip · doi:10.1039/d4lc01043d · Cited by 48
Zhao, Z., Cai, H., Nie, W., Wang, X., Zhao, Z., Fu, Z., Chen, Y., Luo, Z., Lin, Z., Lin, L., et al. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2024-011036 · Cited by 41
A Quick Guide to CAF Subtypes in Pancreatic Cancer
Brichkina, A. I., Polo, P., Sharma, S. D., Visestamkul, N., & Lauth, M. (2023) · Cancers · doi:10.3390/cancers15092614 · Cited by 45
Targeting Cancer‐Associated Fibroblasts: Eliminate or Reprogram?
Yamazaki, M., & Ishimoto, T. (2025) · Cancer Science · doi:10.1111/cas.16443 · Cited by 40
Ben‐Shmuel, A., Gruper, Y., Halperin, C., Levi-Galibov, O., Rosenberg-Fogler, H., Barki, D., Carradori, G., Stein, Y., Yagel, G., Naumova, M., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0131 · Cited by 50
Therapy sculpts the complex interplay between cancer and the immune system during tumour evolution
Thol, K., Pawlik, P., & McGranahan, N. (2022) · Genome Medicine · doi:10.1186/s13073-022-01138-3 · Cited by 47
Perspectives on Hypoxia Signaling in Tumor Stroma
Zhang, Y., Coleman, M., & Brekken, R. A. (2021) · Cancers · doi:10.3390/cancers13123070 · Cited by 39
Self-citationCancer-Associated Fibroblasts: Lessons from Pancreatic Cancer
Sherman, M. H., & di Magliano, M. P. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-035400 · Cited by 39
Kazakova, A. N., Lukina, M. M., Anufrieva, K. S., Bekbaeva, I. V., Ivanova, O. M., Shnaider, P. V., Slonov, A. V., Arapidi, G. P., & Shender, V. О. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1403122 · Cited by 45
Huang, J., Tsang, W. Y., Li, Z., & Guan, X. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.07.001 · Cited by 42
Li, O., Li, L., Sheng, Y., Ke, K., Wu, J., Mou, Y., Liu, M., & Jin, W. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216391 · Cited by 38
Milosevic, V., & Östman, A. (2024) · Upsala Journal of Medical Sciences · doi:10.48101/ujms.v129.10710 · Cited by 38
Liao, T., Chen, X., Qiu, F., Zhang, X., Wu, F., Zhao, Z., Xu, M., Chen, M., Shen, J., Shen, Q., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03217-0 · Cited by 39
Huang, Z., Chen, J., Zhu, T., Li, J., Ng, H. Y., Zhou, Y., Gu, X., Xu, S., & Jia, R. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02533-1 · Cited by 49
Self-citationMurphy, K. J., Chambers, C. R., Herrmann, D., Timpson, P., & Pereira, B. (2021) · Cancers · doi:10.3390/cancers13143481 · Cited by 37
Tanaka, H. Y., Nakazawa, T., Enomoto, A., Masamune, A., & Kano, M. R. (2023) · Cancers · doi:10.3390/cancers15030724 · Cited by 42
Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma
Dolgalev, I., Zhou, H., Murrell, N., Le, H., Sakellaropoulos, T., Coudray, N., Zhu, K., Vasudevaraja, V., Yeaton, A. H., Goparaju, C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42327-x · Cited by 37
Mesothelin Secretion by Pancreatic Cancer Cells Co-opts Macrophages and Promotes Metastasis
Luckett, T., Abudula, M., Ireland, L., Glenn, M. A., Bellomo, G., Stafferton, R., Halloran, C. M., Ghaneh, P., Jones, R. P., Schmid, M. C., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-1542 · Cited by 37
Wang, Y., Qiu, X., Li, Q., Qin, J., Ye, L., Zhang, X., Huang, X., Wen, X., Wang, Z., He, W., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06103-3 · Cited by 37
Self-citationLin, S., Sun, Y., Cao, C., Zhu, Z., Xu, Y., Liu, B., Hu, B., Peng, T., Zhi, W., Xu, M., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104846 · Cited by 38
The Application of Nanoparticles Targeting Cancer-Associated Fibroblasts
Huang, Q., Ge, Y., He, Y. T., Wu, J., Tong, Y., Shang, H., Liu, X., Ba, X., Xia, D., Peng, E., et al. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s447350 · Cited by 35
Transcriptome Landscape of Cancer‐Associated Fibroblasts in Human PDAC
Tao, M., Liu, W., Chen, J., Liu, R., Zou, J., Yu, B., Wang, C., Huang, M., Chen, Q., Zhang, Z., et al. (2025) · Advanced Science · doi:10.1002/advs.202415196 · Cited by 50
Medical Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer
Morgan, A. G., Griffin, M., Kameni, L. E., Wan, D. C., Longaker, M. T., & Norton, J. A. (2023) · Biology · doi:10.3390/biology12081044 · Cited by 40
Stouten, I., van Montfoort, N., & Hawinkels, L. J. A. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108707 · Cited by 35
Han, J., Dong, L., Wu, M., & Ma, F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1160340 · Cited by 36
Clinical Strategies Targeting the Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
Skorupan, N., Domínguez, M. P., Ricci, S. L., & Alewine, C. (2022) · Cancers · doi:10.3390/cancers14174209 · Cited by 35
Oura, K., Morishita, A., Tadokoro, T., Fujita, K., Tani, J., & Kobara, H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413590 · Cited by 35
Cao, Z., Meng, Z., Li, J., Tian, Y., Lu, L., Wang, A., Huang, J., Wang, J., Sun, J., Chen, L., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102017 · Cited by 37
TGF-β inhibitors: the future for prevention and treatment of liver fibrosis?
Wang, W., Gao, Y., Chen, Y., Cheng, M., Sang, Y., Wei, L., Dai, R., Wang, Y., & Zhang, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1583616 · Cited by 37
Strategies for Heating Up Cold Tumors to Boost Immunotherapies
Zabransky, D. J., Yarchoan, M. M., & Jaffee, E. M. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-061421-040258 · Cited by 34
Li, X., Zhou, J., Wang, X., Li, C., Ma, Z., Wan, Q., & Fu, P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1152312 · Cited by 38
Cancer‐associated fibroblasts: Is it a key to an intricate lock of tumorigenesis?
Aden, D., Zaheer, S., Ahluwalia, H., & Ranga, S. (2023) · Cell Biology International · doi:10.1002/cbin.12004 · Cited by 33
Fibroblasts in Orchestrating Colorectal Tumorigenesis and Progression
Abudukelimu, S., de Miranda, N. F. C. C., & Hawinkels, L. J. A. C. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.01.013 · Cited by 34
Zhang, S., Zheng, Y., Yuan, F., Chen, H., & Qiu, Z. (2024) · Cancer Medicine · doi:10.1002/cam4.6959 · Cited by 32
Shinkawa, T., Ohuchida, K., & Nakamura, M. (2022) · Cancers · doi:10.3390/cancers14163994 · Cited by 32
Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer
You, E., Danaher, P. J., Lu, C., Sun, S., Zou, L. S., Phillips, I. E., Rojas, A. S., Ho, N. I., Song, Y., Raabe, M. J., et al. (2024) · Cell · doi:10.1016/j.cell.2024.09.024 · Cited by 31
Macy, A. M., Herrmann, L. M., Adams, A. C., & Hastings, K. T. (2023) · Current Opinion in Immunology · doi:10.1016/j.coi.2023.102330 · Cited by 36
Pancreatic Cancer–Associated Fibroblasts: Where Do We Go from Here?
Carpenter, E. S., Costa, D. B. V., Hasselluhn, M. C., Maitra, A., Olive, K. P., Cukierman, E., di Magliano, M. P., & Sherman, M. H. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-2860 · Cited by 28
Immune vulnerabilities of mutant KRAS in pancreatic cancer
Cheng, N. C., & Vonderheide, R. H. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.07.004 · Cited by 32
Tao, J., Gu, Y., Zhang, Z., Weng, G., Liu, Y., Ren, J., Shi, Y., Qiu, J., Wang, Y., Su, D., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03201-w · Cited by 29
Self-citationAndo, R., Sakai, A., Iida, T., Kataoka, K., Mizutani, Y., & Enomoto, A. (2022) · Cancers · doi:10.3390/cancers14143315 · Cited by 31
Overcoming cancer treatment resistance: Unraveling the role of cancer-associated fibroblasts
Wang, X., Zhou, Y., Wang, Y., Yang, J., Li, Z., Liu, F. L., Wang, A., Gao, Z., Wu, C. H., & Yin, H. (2025) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2025.03.002 · Cited by 32
Cancer‐Associated Fibroblasts: Heterogeneity, Cancer Pathogenesis, and Therapeutic Targets
Li, Y., Liu, Q., Jing, X., Wang, Y., Jia, X., Yang, X., & Chen, K. (2025) · MedComm · doi:10.1002/mco2.70292 · Cited by 32
Chu, X., Yang, Y., & Tian, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179512 · Cited by 27
Qin, C. Y., Zhao, B., Wang, Y., Li, Z., Li, T., Zhao, Y., Wang, W., & Zhao, Y. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12488 · Cited by 29
Cui, C., Zhang, H., Yang, C., Yin, M., Teng, X., Yang, M., Kong, D., Zhang, J., Peng, W., Chu, Z., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-0940 · Cited by 26
Plasticity and Functional Heterogeneity of Cancer-Associated Fibroblasts
Flynn, J. M., Thadani, N., Gallagher, E. E., Azzaro, I., Bodnar, C. M., McCarty, C. P., Romano, G., Webster, M. R., & Capparelli, C. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-3037 · Cited by 30
Metabolic and immune crosstalk between cancer-associated fibroblasts and pancreatic cancer cells
Zhang, Q., Cao, Z., Yan, S., Chen, B., Wu, H., Cao, H., Chen, L., & Liu, Z. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07164-0 · Cited by 30
Blocking EGR1/TGF-β1 and CD44s/STAT3 Crosstalk Inhibits Peritoneal Metastasis of Gastric Cancer
Jin, Y., Wang, C., Zhang, B., Sun, Y., Ji, J. F., Cai, Q., Jiang, J., Zhang, Z., Zhao, L., Yu, B., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.90598 · Cited by 25
Strategies for Overcoming Immune Evasion in Bladder Cancer
Shin, J., Park, J. Y., Kim, S. W., Lee, J., Choi, W. S., & Kim, H. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063105 · Cited by 28
Pereira, B., Ritchie, S., Chambers, C. R., Gordon, K. A., Magenau, A., Murphy, K. J., Nobis, M., Tyma, V. M., Liew, Y. F., Lucas, M. C., et al. (2024) · Science Advances · doi:10.1126/sciadv.adl1197 · Cited by 29
Maddipati, R. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191943 · Cited by 31
Self-citationTumor-instructed glutamine synthesis in cancer-associated fibroblasts promotes pro-tumor macrophages
Li, X., Møller, S. H., Park, J., Chuang, Y., Hsueh, P., Chang, T.-H., Kao, K., Gallart‐Ayala, H., Wang, Y., Peng, J.-J., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20241426 · Cited by 27
Self-citationNext generation patient derived tumor organoids
Podaza, E., Kuo, H., Nguyen, J., Elemento, O., & Martín, M. L. (2022) · Translational research · doi:10.1016/j.trsl.2022.08.003 · Cited by 26
The role of cancer-associated mesothelial cells in the progression and therapy of ovarian cancer
Zheng, A., Wei, Y., Zhao, Y., Zhang, T., & Ma, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1013506 · Cited by 25
Safe engineering of cancer-associated fibroblasts enhances checkpoint blockade immunotherapy
Geng, S., Xiang, T., Zhang, Y., Guo, P., Zhang, H., Zhang, Z., Gu, M., Zhang, K., Song, H., Shi, J., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.02.041 · Cited by 25
Self-citationThe role of immunosuppressive myofibroblasts in the aging process and age-related diseases
Salminen, A. (2023) · Journal of Molecular Medicine · doi:10.1007/s00109-023-02360-1 · Cited by 26
Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes
Sun, Y., Yinwang, E., Wang, S., Wang, Z., Wang, F., Xue, Y., Zhang, W., Zhao, S., Mou, H., Chen, S., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02104-w · Cited by 29
Self-citationLiu, X., Yang, J., Huang, S., Hong, Y., Zhu, Y., Wang, J., Wang, Y., Liang, T., & Bai, X. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.01.023 · Cited by 27
Zhang, X., Wang, Y., Cui, W., Li, D., Song, J., Liu, Y., Liu, Y., & Yang, S. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101273 · Cited by 26
Fan, C., Zhu, W., Chen, Y., Zhu, W., & Ding, J. (2025) · MedComm · doi:10.1002/mco2.70415 · Cited by 30
Minz, A. P., Mohapatra, D., Dutta, M., Sethi, M., Parida, D., Mohapatra, A. P., Mishra, S., Kar, S., Sasmal, P. K., & Senapati, S. (2023) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-023-03562-9 · Cited by 24
Antigen-presenting fibroblasts: emerging players in immune modulation and therapeutic targets
Chen, X., Chen, F., Jia, S., Lu, Q., & Zhao, M. F. (2025) · Theranostics · doi:10.7150/thno.104900 · Cited by 23
Zhang, Z., Tang, Y., Luo, D., Qiu, J. L., & Chen, L. (2025) · APL Bioengineering · doi:10.1063/5.0244706 · Cited by 26
The plasticity of cancer-associated fibroblasts
Xia, Z., & Wever, O. D. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.04.012 · Cited by 27
Varinelli, L., Battistessa, D., Guagliò, M., Zanutto, S., Illescas, O., Lorenc, E., Pisati, F., D, S. K. M., Cattaneo, L., Sabella, G., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03052-5 · Cited by 24
Du, W., di Magliano, M. P., & Zhang, Y. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.682217 · Cited by 22
Self-citationCAFs vs. TECs: when blood feuds fuel cancer progression, dissemination and therapeutic resistance
Coursier, D., & Calvo, F. (2024) · Cellular Oncology · doi:10.1007/s13402-024-00931-z · Cited by 23
An, Q., Duan, L., Wang, Y., Wang, F., Liu, X., Liu, C., & Hu, Q. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06167-1 · Cited by 28
Single‐cell advances in stromal‐leukocyte interactions in cancer
Wu, S. Z., & Swarbrick, A. (2021) · Immunological Reviews · doi:10.1111/imr.12976 · Cited by 21
T cell–Mediated Development of Stromal Fibroblasts with an Immune-Enhancing Chemokine Profile
Yan, R., Moresco, P., Gegenhuber, B., & Fearon, D. T. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0593 · Cited by 24
Suzuki, Y., SATO, T. A., Sugimori, M., Kanemaru, Y., Onodera, S., Tsuchiya, H., Nakamori, Y., Tsuyuki, S., Ikeda, A., Ikeda, R., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-68061-y · Cited by 24
Badran, O., Cohen, I., & Bar‐Sela, G. (2025) · Cells · doi:10.3390/cells14171398 · Cited by 25
Li, M., Wu, B., Li, L., Lv, C., & Tian, Y. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188945 · Cited by 23
Cancer-associated mesothelial cells are regulated by the anti-Müllerian hormone axis
Chauvin, M. Y., Meinsohn, M.-C., Dasari, S., May, P., Iyer, S., Nguyen, N. M., Oliva, E., Lucchini, Z., Nagykery, N. G., Kashiwagi, A., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112730 · Cited by 21
The neoantigens derived from transposable elements – A hidden treasure for cancer immunotherapy
Hu, Z., Guo, X., Li, Z., Meng, Z., & Huang, S. (2024) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2024.189126 · Cited by 23
Ren, F., Meng, L., Zheng, S., Cui, J., Song, S., Li, X., Wang, D., Li, X., Liu, Q., Bu, W., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03290-1 · Cited by 21
Rethinking the Roles of Cancer-Associated Fibroblasts in Pancreatic Cancer
Francescone, R., Crawford, H. C., & Costa, D. B. V. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.01.022 · Cited by 20
Focal adhesion kinase priming in pancreatic cancer, altering biomechanics to improve chemotherapy
Murphy, K. J., Zhu, J., Trpceski, M., Pereira, B., Timpson, P., & Herrmann, D. (2022) · Biochemical Society Transactions · doi:10.1042/bst20220162 · Cited by 19
Saúde-Conde, R., Öztürk, A. A., Stosic, K., Senar, O. A., Navez, J., Bouchart, C., Arsenijevic, T., Flamen, P., & Laethem, J. V. (2024) · Biomedicines · doi:10.3390/biomedicines12030591 · Cited by 20
Yamashita, K., & Kumamoto, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116003 · Cited by 20
Challenges and Opportunities in Targeting the Complex Pancreatic Tumor Microenvironment
Finan, J. M., Guo, Y., Goodyear, S. M., & Brody, J. R. (2024) · JCO oncology advances. · doi:10.1200/oa-24-00050 · Cited by 21
Molecular phenotypes and spatial archetypes: A new framework for cancer-associated fibroblasts
Liu, Y., Chen, X., Dai, Y., Jia, Y., Kieffer, Y., Xie, L., Zhou, Z., Tyler, L. A., Kim, A. C., Biffi, G., et al. (2026) · Cancer Cell · doi:10.1016/j.ccell.2026.06.001 · Cited by 19
Self-citationCancer-associated fibroblasts as accomplices to confer therapeutic resistance in cancer
Wang, W., Cheng, B., & Yu, Q. (2022) · Cancer Drug Resistance · doi:10.20517/cdr.2022.67 · Cited by 18
Fard, D., Giraudo, E., & Tamagnone, L. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.07.009 · Cited by 22
Toshida, K., Itoh, S., Iseda, N., Tomiyama, T., Yoshiya, S., Toshima, T., Liu, Y., Iwasaki, T., Okuzaki, D., Taniguchi, K., et al. (2024) · Liver International · doi:10.1111/liv.15839 · Cited by 19
CAFs and T cells interplay: The emergence of a new arena in cancer combat
Chen, M., Chen, F., Gao, Z., Li, X., Hu, L., Yang, S., Zhao, S., & Song, Z. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117045 · Cited by 20
Unraveling the role of cancer-associated fibroblasts in colorectal cancer
Cui, J., Ma, J., Gao, X., Sheng, Z.-M., Pan, Z., Shi, L., & Zhang, B. (2024) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v16.i12.4565 · Cited by 19
Lloyd, E. G., Jihad, M., Manansala, J. S., Li, W., Cheng, P. S. W., Teles, S. P., Mucciolo, G., Henríquez, J. A., Ashworth, S., Luo, W., et al. (2025) · Cancer Research · doi:10.1158/0008-5472.can-24-2330 · Cited by 18
CD4+ T cell dysfunction in cancer
Venkatesh, H., & Fong, L. H. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20241417 · Cited by 19
Luo, J., Xiang, X., Gong, G., & Jiang, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1617662 · Cited by 23
Jayaprakash, M., Kumar, D. V., Chakraborty, G., Chakraborty, A., & Kumar, V. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118559 · Cited by 21
Sun, L., Zheng, M., Gao, Y., Brigstock, D. R., & Gao, R. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176374 · Cited by 22
Vascular disease persistence in giant cell arteritis: are stromal cells neglected?
Karabayas, M., Ibrahim, H., Roelofs, A. J., Reynolds, G., Kidder, D., & Bari, C. D. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-225270 · Cited by 18
Metadata
- Authors
- Huang, H., Wang, Z., Zhang, Y., Pradhan, R. N., Ganguly, D., Chandra, R., Murimwa, G., Wright, S., Gu, X., Maddipati, R., Müller, S., Turley, S. J., & Brekken, R. A.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- University of California San Diego (US)
- Genentech (US)
- Corresponding author
- Huang, Huocong
- Brekken, Rolf A.
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2022-06
- Volume
- 40
- Issue
- 6
- Pages
- 656-673.e7
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC9197998
- OpenAlex
- W4229052987
- Cited by
- 542
- References
- 62
- Citations by year
- 2026: 112 · 2025: 158 · 2024: 144 · 2023: 80 · 2022: 41
- FWCI
- 44.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- SSRN Electronic Journal (acceptedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (CA210181, CA243577, CA252009)
- Burroughs Wellcome Fund
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- mesothelial cells, regulatory T cells, pancreatic cancer, tumor immune evasion, mesothelin, interleukin-1, TGF-beta, MHC class II, CD4+ T cell tolerance, lineage tracing, cancer immunotherapy
- MeSH terms
- Cancer-Associated Fibroblasts, Fibroblasts, Humans, Pancreatic Neoplasms, Transforming Growth Factor beta, T-Lymphocytes, Regulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
